iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDD) Shares Down 0.2% – Here’s What Happened

iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDDGet Free Report)’s stock price were down 0.2% during mid-day trading on Thursday . The stock traded as low as $30.73 and last traded at $30.75. Approximately 15,657 shares changed hands during trading, an increase of 119% from the average daily volume of 7,154 shares. The stock had previously closed at $30.80.

iShares LifePath Target Date 2040 ETF Trading Down 0.2 %

The company has a 50-day moving average of $31.14 and a 200-day moving average of $31.16. The firm has a market capitalization of $27.68 million, a P/E ratio of 20.96 and a beta of 0.81.

Hedge Funds Weigh In On iShares LifePath Target Date 2040 ETF

An institutional investor recently bought a new position in iShares LifePath Target Date 2040 ETF stock. Heck Capital Advisors LLC bought a new stake in shares of iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDDFree Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,310 shares of the company’s stock, valued at approximately $40,000. Heck Capital Advisors LLC owned 0.47% of iShares LifePath Target Date 2040 ETF as of its most recent filing with the Securities and Exchange Commission.

iShares LifePath Target Date 2040 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2040 ETF (ITDD) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.

Featured Stories

Receive News & Ratings for iShares LifePath Target Date 2040 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2040 ETF and related companies with MarketBeat.com's FREE daily email newsletter.